BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

CUSIP: 090572207

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
19,799,636
Share change
+1,302,325
Total reported value
$5,407,155,613
Put/Call ratio
161%
Price per share
$273.11
Number of holders
428
Value change
+$314,233,620
Number of buys
179
Number of sells
255

Quarterly Holders Quick Answers

What is CUSIP 090572207?
CUSIP 090572207 identifies BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
48%
2,421,334
$837,466,790 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
29%
1,479,904
$511,854,295 31 Mar 2024
13F
Veritas Asset Management LLP
13F
Company
23%
1,147,097
$396,746,439 31 Mar 2024
13F
STATE STREET CORP
13F
Company
17%
873,675
$302,177,972 31 Mar 2024
13F
EARNEST PARTNERS LLC
13F
Company
10%
514,906
$178,090,538 31 Mar 2024
13F
Select Equity Group, L.P.
13F
Company
10%
514,666
$178,007,529 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
9.3%
473,201
$163,264,283 31 Mar 2024
13F
Invesco Ltd.
13F
Company
9.1%
461,006
$159,448,145 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
8.3%
422,157
$146,011,443 31 Mar 2024
13F
Ninety One UK Ltd
13F
Company
8.3%
420,600
$145,472,922 31 Mar 2024
13F
THOMPSON SIEGEL & WALMSLEY LLC
13F
Company
6.9%
350,014
$121,059,000 31 Mar 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
6.8%
347,252
$120,104,050 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
6.8%
344,568
$119,175,735 31 Mar 2024
13F
SOUTHEASTERN ASSET MANAGEMENT INC/TN/
13F
Company
6.8%
343,959
$118,965,100 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5.9%
300,904
$104,073,667 31 Mar 2024
13F
Hound Partners, LLC
13F
Company
5.2%
264,537
$91,495,412 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
5%
253,533
$87,689,458 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
mixed-class rows
253,064
mixed-class rows
$87,523,785 31 Mar 2024
13F
PARNASSUS INVESTMENTS, LLC
13F
Company
4.7%
237,790
$82,244,427 31 Mar 2024
13F
NORGES BANK
13F
Company
4.6%
234,806
$81,212,351 31 Mar 2024
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
4.5%
230,509
$79,726,148 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
4.4%
223,441
$77,281,538 31 Mar 2024
13F
SEI INVESTMENTS CO
13F
Company
3.7%
186,626
$64,549,981 31 Mar 2024
13F
Artisan Partners Limited Partnership
13F
Company
3.5%
179,840
$62,201,261 31 Mar 2024
13F
Parsifal Capital Management, LP
13F
Company
3.5%
178,013
$61,569,356 31 Mar 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
3.2%
163,783
$56,647,667 31 Mar 2024
13F
Bellevue Group AG
13F
Company
3.1%
156,618
$54,169,468 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
3.1%
155,360
$53,734,422 31 Mar 2024
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
3%
152,378
$52,702,979 31 Mar 2024
13F
GW&K Investment Management, LLC
13F
Company
2.7%
137,886
$47,691,000 31 Mar 2024
13F
Mawer Investment Management Ltd.
13F
Company
2.6%
133,353
$46,122,802 31 Mar 2024
13F
QVIDTVM Management LLC
13F
Company
2.5%
125,938
$43,558,176 31 Mar 2024
13F
Tikvah Management LLC
13F
Company
2.3%
118,147
$40,863,503 31 Mar 2024
13F
Legal & General Group Plc
13F
Company
2.3%
117,193
$40,533,315 31 Mar 2024
13F
Nitorum Capital, L.P.
13F
Company
2.2%
111,653
$38,617,423 31 Mar 2024
13F
DEUTSCHE BANK AG\
13F
Company
2.1%
106,451
$36,818,207 31 Mar 2024
13F
FMR LLC
13F
Company
2.1%
105,193
$36,383,214 31 Mar 2024
13F
First Pacific Advisors, LP
13F
Company
2.1%
104,739
$36,226,078 31 Mar 2024
13F
ANCHOR CAPITAL ADVISORS LLC
13F
Company
2%
100,031
$34,597,738 31 Mar 2024
13F
Southpoint Capital Advisors LP
13F
Company
2%
100,000
$34,587,000 31 Mar 2024
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
2%
99,866
$34,540,725 31 Mar 2024
13F
Grantham, Mayo, Van Otterloo & Co. LLC
13F
Company
1.8%
93,352
$32,287,656 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
1.8%
91,477
$31,689,710 31 Mar 2024
13F
Portolan Capital Management, LLC
13F
Company
1.8%
90,992
$31,471,403 31 Mar 2024
13F
FEDERATED HERMES, INC.
13F
Company
1.8%
90,183
$31,191,595 31 Mar 2024
13F
Fisher Asset Management, LLC
13F
Company
1.6%
80,943
$27,995,754 31 Mar 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
1.6%
79,464
$27,484,057 31 Mar 2024
13F
Marathon Asset Management Ltd
13F
Company
1.5%
75,857
$26,235,391 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
1.4%
72,770
$25,168,960 31 Mar 2024
13F
FRANKLIN RESOURCES INC
13F
Company
1.4%
72,423
$25,048,943 31 Mar 2024
13F

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q2 2024

As of 30 Jun 2024, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 428 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,799,636 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Veritas Asset Management LLP, STATE STREET CORP, VAN ECK ASSOCIATES CORP, Select Equity Group, L.P., First Eagle Investment Management, LLC, EARNEST PARTNERS LLC, Invesco Ltd., and DIMENSIONAL FUND ADVISORS LP. This page lists 429 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
456
Q2 2024 holders
428
Holder diff
-28
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .